Status:
UNKNOWN
High-Dose Influenza Vaccine in Nursing Homes
Lead Sponsor:
Insight Therapeutics, LLC
Collaborating Sponsors:
Brown University
Case Western Reserve University
Conditions:
Influenza
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to prospectively evaluate relative effectiveness of high dose influenza vaccine in preventing influenza mortality, hospitalization, and functional decline in a nursing hom...
Detailed Description
SUMMARY: This nationally representative study samples from estimated 6782 Medicare-certified nursing homes co-located within 50 miles of the 122 cities reporting to Center for Disease Control and Prev...
Eligibility Criteria
Inclusion
- Long-term care facilities within 50 miles of one of the 122 cities that serve as CDC surveillance sites
Exclusion
- Facilities already systematically administering HD vaccine to their residents
- Facilities having fewer than 50 long-stay residents
- Hospital-based facilities
- Facilities with more than 20% of the population under age 65
- Facilities not submitting Minimum Data Set (MDS) data
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
823 Patients enrolled
Trial Details
Trial ID
NCT01815268
Start Date
February 1 2013
End Date
September 1 2018
Last Update
July 16 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Case Western Reserve University
Cleveland, Ohio, United States, 44106
2
Brown University
Providence, Rhode Island, United States, 02912
3
Insight Therapeutics, LLC
Norfolk, Virginia, United States, 23510